TY - JOUR
T1 - Gold-silver alloy nanoshells
T2 - A new candidate for nanotherapeutics and diagnostics
AU - Gheorghe, Dana E.
AU - Cui, Lili
AU - Karmonik, Christof
AU - Brazdeikis, Audrius
AU - Penaloza, Jose M.
AU - Young, Joseph K.
AU - Drezek, Rebekah A.
AU - Bikram, Malavosklish
N1 - Funding Information:
We thank Dr. Irene Rusakova for assistance with TEM analysis. We also gratefully acknowledge the financial support of this study that was made available from the Department of Defense (DOD) (OC073093) and Texas Higher Education Coordinating Board-ARP Award (003652-0217-2007).
PY - 2011
Y1 - 2011
N2 - We have developed novel gold-silver alloy nanoshells as magnetic resonance imaging (MRI) dual T 1 (positive) and T 2 (negative) contrast agents as an alternative to typical gadolinium (Gd)-based contrast agents. Specifically, we have doped iron oxide nanoparticles with Gd ions and sequestered the ions within the core by coating the nanoparticles with an alloy of gold and silver. Thus, these nanoparticles are very innovative and have the potential to overcome toxicities related to renal clearance of contrast agents such as nephrogenic systemic fibrosis. The morphology of the attained nanoparticles was characterized by XRD which demonstrated the successful incorporation of Gd(III) ions into the structure of the magnetite, with no major alterations of the spinel structure, as well as the growth of the gold-silver alloy shells. This was supported by TEM, ICP-AES, and SEM/EDS data. The nanoshells showed a saturation magnetization of 38 emu/g because of the presence of Gd ions within the crystalline structure with r 1 and r 2 values of 0.0119 and 0.9229 mL mg -1 s -1, respectively (Au:Ag alloy = 1:1). T 1- and T 2-weighted images of the nanoshells showed that these agents can both increase the surrounding water proton signals in the T 1-weighted image and reduce the signal in T 2-weighted images. The as-synthesized nanoparticles exhibited strong absorption in the range of 600-800 nm, their optical properties being strongly dependent upon the thickness of the gold-silver alloy shell. Thus, these nanoshells have the potential to be utilized for tumor cell ablation because of their absorption as well as an imaging agent.
AB - We have developed novel gold-silver alloy nanoshells as magnetic resonance imaging (MRI) dual T 1 (positive) and T 2 (negative) contrast agents as an alternative to typical gadolinium (Gd)-based contrast agents. Specifically, we have doped iron oxide nanoparticles with Gd ions and sequestered the ions within the core by coating the nanoparticles with an alloy of gold and silver. Thus, these nanoparticles are very innovative and have the potential to overcome toxicities related to renal clearance of contrast agents such as nephrogenic systemic fibrosis. The morphology of the attained nanoparticles was characterized by XRD which demonstrated the successful incorporation of Gd(III) ions into the structure of the magnetite, with no major alterations of the spinel structure, as well as the growth of the gold-silver alloy shells. This was supported by TEM, ICP-AES, and SEM/EDS data. The nanoshells showed a saturation magnetization of 38 emu/g because of the presence of Gd ions within the crystalline structure with r 1 and r 2 values of 0.0119 and 0.9229 mL mg -1 s -1, respectively (Au:Ag alloy = 1:1). T 1- and T 2-weighted images of the nanoshells showed that these agents can both increase the surrounding water proton signals in the T 1-weighted image and reduce the signal in T 2-weighted images. The as-synthesized nanoparticles exhibited strong absorption in the range of 600-800 nm, their optical properties being strongly dependent upon the thickness of the gold-silver alloy shell. Thus, these nanoshells have the potential to be utilized for tumor cell ablation because of their absorption as well as an imaging agent.
UR - http://www.scopus.com/inward/record.url?scp=84856026668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856026668&partnerID=8YFLogxK
U2 - 10.1186/1556-276X-6-554
DO - 10.1186/1556-276X-6-554
M3 - Article
C2 - 21995302
AN - SCOPUS:84856026668
VL - 6
SP - 1
EP - 12
JO - Nanoscale Research Letters
JF - Nanoscale Research Letters
SN - 1931-7573
M1 - 554
ER -